Dynavax(DVAX) - 2024 Q1 - Quarterly Results

Exhibit 99.1 Dynavax Reports First Quarter 2024 Financial Results and Provides Business Updates EMERYVILLE, CA – May 8, 2024 – Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today reported financial results and provided a business update for the quarter ended March 31, 2024. "The first quarter of 2024 saw continued year-over-year growth in quarterly HEPLISAV-B net product revenue. As we expected, growth in the ...